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Abstract – Feline coronaviruses (FCoV) comprise two biotypes: feline enteric coronaviruses (FECV) and
feline infectious peritonitis viruses (FIPV). FECV is associated with asymptomatic persistent enteric
infections, while FIPV causes feline infectious peritonitis (FIP), a usually fatal systemic disease in domestic
cats and some wild Felidae. FIPVarises from FECV by mutation. FCoValso occur in two serotypes, I and
II, of which the serotype I viruses are by far the most prevalent in the ﬁeld. Yet, most of our knowledge
about FCoV infections relates to serotype II viruses, particularly about the FIPV, mainly because type I
viruses grow poorly in cell culture. Hence, the aim of the present work was the detailed study of the
epidemiologically most relevant viruses, the avirulent serotype I viruses. Kittens were inoculated oronasally
with different doses of two independent FECV ﬁeld strains, UCD and RM. Persistent infection could be
reproducibly established. The patterns of clinical symptoms, faecal virus shedding and seroconversion were
monitored for up to 10 weeks revealing subtle but reproducible differences between the two viruses. Faecal
virus, i.e. genomic RNA, was detected during persistent FECV infection only in the large intestine,
downstream of the appendix, and could occasionally be observed also in the blood. The implications of our
results, particularly our insights into the persistently infected state, are discussed.
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1. INTRODUCTION
Feline coronaviruses (FCoV) present them-
selves in different forms. First of all there are
two biotypes, the low- or avirulent viruses and
the highly virulent ones. The former viruses
cause intestinal infection with no or only mild
clinical manifestations, i.e. diarrhoea in young
kittens. These so-called feline enteric coronavi-
ruses (FECV) are the predominant pathotype
in the ﬁeld. FECV infection often persists in
apparentlyhealthyanimals,whichshedthevirus
in their faeces. Natural infection occurs via the
faecal-oral route. FECV infection appears to be
mainly restricted to the intestinal tract where
the virus replicates in villous epithelial cells.
The virulent pathotype, feline infectious perito-
nitis virus (FIPV), causes severe systemic infec-
tion with lesions in many organs and tissues,
most typically in the peritoneum, hence the dis-
ease’s name feline infectious peritonitis (FIP).
Unlike FECV, FIPV does not spread readily
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spontaneous mutation from FECV in individual
animals [4, 24, 26, 30] often under conditions of
immune suppression due to medication or co-
infection [26]. FIP is a highly fatal disease that
occurs in domestic cats and some wild felidae
usually between 3 and 16 months of age. The
disease is currently the leading infectious cause
of death in domestic cats. In catteries 80 to 90%
of the animals are usually feline coronavirus
seropositive, in single cat households seroposi-
tivity often varies between 10 and 50% [20].
From the seropositive cats, 5 to 12% eventually
develop FIP [1]. There is at present no effective
way to prevent the infection or treat the disease.
For recent reviews on FCoV, see Haijema et al.
[11] and Pedersen [25].
FCoValso occur as two serotypes. Based on
in vitro neutralization tests, serotypes I and II
have been distinguished [15, 25], which can
in turn be of either pathotype. In the ﬁeld the
serotype I viruses are largely predominant; they
are responsible for 70 to 95% of FCoV
morbidity and mortality. In Europe and in the
USA type II viruses are quite rarely observed,
in contrast to Japan where they were reported
to constitute some 20 to 30% of all viruses [16].
Research on FCoVinfection has understand-
ably focused mainly on FIPV, its origin, its par-
ticular pathogenesis and disease. Moreover,
mostofwhatweknowaboutthesevirusescomes
from work with serotype II viruses, simply
becauseefﬁcientinvitropropagationofserotype
I viruses has not yet been achieved. Hence, in
order to learn more about the characteristics of
the most prevalent FCoV infection in the ﬁeld,
wehaveinthisstudysetupanimalinfectionsys-
tems for serotype I FECV. Using two indepen-
dent ﬁeld isolates we reproducibly observed
persistent infection of which we evaluated the
clinical, virological and serological features.
2. MATERIALS AND METHODS
2.1. Viruses
Faecal extracts containing an unknown titre of
FECV strain UCD [23] and FECV strain RM [26]
were kindlyprovidedbyN.C. Pedersen andA. Poland
(both Davis, CA, USA), respectively. They were used
to prepare stocks of these viruses for our infection
experiments as follows. Speciﬁc pathogen-free (SPF)
kittens were inoculated oronasally with an aliquot of
the faecal sample. Faeces were collected daily and
suspended in an equal volume of phosphate buffered
saline (PBS). The suspensions were centrifuged at
30 0 0· g for 10 min and the viral genome contents
in the supernatants determined by quantitative RT-
PCR (see below). Extracts with the highest concentra-
tions of viral RNA were combined, aliquoted and
stored frozen at  80  C. The RNA content of the
FECV UCD and FECV RM stocks were 1 · 10
6
and 4 · 10
7 genome equivalents per lL, respectively.
2.2. Cats
SPF cats (Harlan Sprague Dawley, Inc., Madison,
USA), seronegative for FCoVas checked by standard
immunoﬂuorescence assay, were used in all infection
experiments. The animals were housed in groups in a
closed animal facility. They were euthanized at the
indicated end of each experiment by intravenous
injection with an overdose of phenobarbital. For all
experiments, approval of the university’s Ethical
Committee was obtained.
2.3. Design of animal infection experiments
With the aim to reproducibly establish persistence
by experimental FECVinfection, to elucidate possible
differences in pathogenic characteristics among differ-
ent strains, and to investigate possible dose-dependent
differences in these characteristics, four experimental
infections were performed, two with each of the
FECV strains. In the ﬁrst experiment with FECV
UCD (experiment A1, Tab. I) two male SPF cats of
11 weeks old were inoculated oronasally each with
0.5 mL (i.e. 5 · 10
8 genome equivalents) of the
FECV UCD faecal extract. The animals were moni-
t o r e dd u r i n g3 5d a y sp o s ti n o c u l a t i o nf o rc l i n i c a l
signs, faecal virus shedding and serum antibody titres.
In the second infection experiment with FECV UCD
(experiment A2, Tab. I) eight female SPF cats, 11
weeks old and housed in four groups of two animals,
were inoculated oronasally with 0.5 mL per cat of a
series of 10-fold dilutions of the FECV UCD stock:
undiluted and diluted 10
 1,1 0
 2 and 10
 3 in PBS
(two cats per dose). The cats were monitored for clin-
ical signs, body weight, faecal virus shedding and
serum antibody titres for 70 days post inoculation.
In the ﬁrst infection experiment with FECV RM
(experiment B1, Tab. I)f o u rf e m a l eS P Fc a t so f1 8
weeks old were inoculated oronasally with 0.5 mL
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faecal extract and monitored similarly for 71 days
post inoculation. In the second experiment with this
virus (experiment B2, Tab. I) eight female SPF cats,
18 weeks old and housed in pairs, were inoculated
oronasally with 0.5 mL per cat of several dilutions
of the FECV RM stock: undiluted and diluted
10
 2,1 0
 3 and 10
 4 in PBS (two cats per dose).
They were again monitored for the standard parame-
ters for 70 days post inoculation.
Monitoring of clinical signs was done on a daily
basis by scoring for such signs as depression, general
activity, anorexia and faeces consistency. The body
temperature and body weight were determined once
or twice a week. Body weight was expressed as the
percentage of the body weight measured at the day
of inoculation.
2.4. Quantitative RT-PCR
To monitor faecal virus shedding, quantitative RT-
PCR was performed using the TaqMan
  procedure
described by Gut et al. [9], which targets the con-
served 7b gene in the 30 domain of the FCoV gen-
ome. To extract template RNA from faecal
samples, faeces were weighed, suspended and diluted
1:1 (w/v) with PBS and centrifuged at 3 000 · g for
10 min to remove large particles. RNAwas extracted
from the suspension using guanidinium thiocyanate
with adsorption of viral RNA onto silica as described
by Boom et al. [3]. The eluted RNAwas diluted 1:10
in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH
8.0) before addition to the PCR mixture.
The 25 lL PCR mixture contained 12.5 lL
Master Mix and 0.63 lL Multiscribe and RNase
Inhibitor Mix (Applied Biosystems, Nieuwerkerk
a/d IJssel, The Netherlands), 0.2 lMf o r w a r dp r i m e r
FCoV1128f, 2 lM reverse primer FCoV1229r,
0.3 lM probe FCoV1200p and 2 lL template RNA
or diluted standard (described in next paragraph).
After a reverse transcription step of 30 min at 48  C
and a denaturation step of 10 min at 95  C, 40 cycles,
each 15 s at 95  C and 1 min at 60  C, were per-
formed. Reverse transcription, ampliﬁcation and real
time monitoring of ﬂuorescence were carried out in
an ABI Prism
  7000 Sequence Detector.
A synthetic RNA standard for absolute quantiﬁca-
tion was produced using as a template the
pST-blue102 plasmid (kindly provided by Virbac
Laboratories Inc., Carros, France) containing a cDNA
copy of the RNA fragment to be ampliﬁed in our
assay behind the T7 RNA promoter. The transcrip-
tion reaction sample was DNAse-treated, the RNA
puriﬁed by phenol/chloroform extraction and isopro-
panol precipitation, and the amount of RNA deter-
mined by UV spectrophotometry. The RNA stock
was aliquoted and frozen at  80  C. RNA dilutions
were tested by TaqMan
  analysis, showing a linear
relationship between the amount of input RNA and
the Ct value over a range of at least 5 log units,
corresponding to 3 · 10
3 through 3 · 10
8 molecules
(data not shown).
2.5. Radioimmunoprecipitation assay (RIPA)
Twenty-ﬁve lLo f
35S-methionine labelled FCoV
(strain 79-1146) infected cell lysate was mixed with
1 mL TESV buffer (20 mM Tris-HCl pH 7.3, 1 mM
EDTA, 100 mM NaCl) containing 1% Triton X-
100, 0.1 mg/mL BSA (Sigma A-7888, Sigma
Aldrich, Zwijndrecht, The Netherlands) and 0.25%
SDS, to which 15 lL cat serum was added. Ascitis
(#9912; 3 lL), obtained from an experimentally FIPV
79-1146 (serotype II) infected cat [10], and anti-RM
Table I. Overview of the experimental set-up.
Exp. no. FECV
strain
Virus doses
(genome equivalents/lL)
Dilutions No. of cats Age
(weeks)
Sex Observ. period
(days)
A1 UCD 5 · 10
8 Undiluted 2 11 M 35
A2 UCD 5 · 10
8 Undiluted 2
11 F 70 5 · 10
7 10
 1 2
5 · 10
6 10
 2 2
5 · 10
5 10
 3 2
B1 RM 2 · 10
10 Undiluted 4 18 F 71
B2 RM 2 · 10
10 Undiluted 2
18 F 70 2 · 10
8 10
 2 2
2 · 10
7 10
 3 2
2 · 10
6 10
 4 2
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(serotype I) infected cat, were used as positive con-
trols. The mixtures were incubated overnight at
4  C .T h ei m m u n ec o m p l e x e sw e r ea d s o r b e dt o
50 lL Pansorbin cells (Calbiochem; Merck KGaA,
Darmstadt, Germany) for 30 min at 4  C. After
centrifugation the pellets were washed three times
with RIPA-buffer (10 mM Tris-HCl pH 7.4, 0.1%
SDS, 1% DOC (w/v), 1% NP40 and 150 mM NaCl).
TheﬁnalpelletswereresuspendedinLaemmlisample
buffer and heated at 95  C for 1 min. The precipitates
were analysed by SDS-PAGE using a 10% polyacryl-
amide gel. After electrophoresis the gel was ﬁxed in
50% methanol containing 10% acetic acid, dried
and the radioactivity visualized by autoradiography.
2.6. ELISA
Serum antibody titres were determined by a type-
speciﬁc ELISA. Microtiter plates (96 wells; Micro-
lon, Greiner Bio-one International B.V., Alphen a/d
Rijn, The Netherlands) were coated with 200 ng
whole virus particles of a cell culture adapted deriv-
ative of the serotype I FCoV strain UCD-1 [22].
The virus was grown on felis catus whole fetus
(fcwf-4) cells [22], which were maintained as mono-
layer cultures in Dulbecco’s modiﬁed Eagle’s med-
ium containing 10% foetal calf serum, 100 IU of
penicillin/mL, and 100 lg of streptomycin/mL (all
from Life Technologies Ltd., Paisley, UK). The virus
was puriﬁed from the clariﬁed cell culture superna-
tant by ultracentrifugation through a 20% (w/w)
sucrose cushion. Pellets were resuspended in TM
buffer (20 mM Tris-HCl and 20 mM MgCl2 adjusted
to pH 7.0) and protein content determined with the
Bio-Rad DC Protein Assay (Bio-Rad Laboratories
B.V., Veenendaal, The Netherlands). The plates were
incubated with the virus, dissolved in 0.1 M carbon-
ate buffer pH 9.6, for 1.5 h at 37  C and overnight at
4  C. Plates were blocked with 1% BSA in PBS-
Tween20 (0.05%) for 1 h at 37  C. The plates were
washed three times with PBS-Tween20 (0.05%),
2-fold serial dilutions of cat serum in PBS-Tween20
were added to the wells and the plates were incubated
at room temperature for 1 h. After washing the plates
again with PBS-Tween20, peroxidase-conjugated
goat anti-cat IgG (Cappel Laboratories Inc.,
Downingtown, USA) was added to the wells and
the plates were again incubated at room temperature
for 1 h. Subsequently, the plates were rinsed and
100 lL substrate solution containing 0.1 mg/mL tet-
ramethylbenzidine-H2O2 in 0.1 M sodium acetate
was added to the wells. The substrate reaction was
stopped by the addition of 50 lL2MH 2SO4.T h e
absorbance at 450 nm was determined on a EL808
Ultra Microplate Reader (BioTek Instruments, Inc.,
Winooski, USA). A titration curve was obtained by
plotting the optical density as a function of the reci-
procal serum dilution. The titre was deﬁned as the
highest dilution of serum corresponding to an optical
density of 0.2 above the background, as extrapolated
from the slope of the curve (background values were
determined using a FCoV negative serum). The sig-
niﬁcance of the differences in the serum antibody ti-
tres was analyzed using Student’s t-test.
2.7. Detection of viraemia
In order to detect the presence of viral RNA in
blood, EDTA blood was centrifuged for 10 min at
2500 rpm. After separation of the plasma one volume
of PBS was added to the blood cells and total RNA
was isolated using the Total Quick RNA Blood Kit
Protocol (Talent, Trieste, Italy). Quantitative RT-
PCR to detect viral genomic RNA was performed
as described above. For the detection of subgenomic
mRNA we used a RT-PCR protocol targeting the
mRNA specifying the viral membrane (M) protein
as described earlier [28].
2.8. Localization of virus in the gut
To longitudinally screen the intestinal tract of per-
sistently FECV infected cats for virus, the intestines
of freshly euthanized animals were sectioned over
their entire length into segments of 5 cm (ﬁrst part
until appendix) or 1 cm (remainder). The faecal con-
tent of each segment was collected in an eppendorf
tube and subsequently the tissue segment was washed
out thoroughly with cold PBS. The faecal material
was suspended in an equal volume of PBS and cen-
trifuged for 20 min at 3 000 rpm. The supernatant
was collected, RNA was extracted and the viral gen-
ome content was quantitated by real-time RT-PCR as
described above. For RNA isolation from the intesti-
nal tissue, the washed segments were lysed overnight
in lysis buffer L6 and subsequently the RNA was
puriﬁed and concentrated by the guanidinium thiocy-
anate-silica (SiO2) protocol of Boom et al. [3].
2.9. Immunohistochemistry of gut tissue
sections
Segments of the gut found FCoV positive by RT-
PCR were stained for the presence of antigen within
cells.Sectionsofthegutweredeparafﬁnizedinxylene
a n dr e h y d r a t e dt h r o u g hg r a d e da l c o h o l s .A f t e r
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heating using a microwave oven, endogenous peroxi-
dase activity was blocked using hydrogen peroxide
(1%) in methanol and subsequently sections were
blockedwithnormalgoatserum.Afterincubationwith
a primary antiserum (mouse anti-feline coronavirus
MCA2194, AbD Serotec, Du ¨sseldorf, Germany) a
goat anti mouse Envision complex was added (Dako,
Heverlee,Belgium).Subsequentlysectionswereincu-
bated with 3,3’-diaminobenzidine tetrahydrochloride
and counterstained with Papanicolaou’s hematoxylin.
3. RESULTS
3.1. Infection of cats with FECV UCD
and FECV RM
Experiments A1 and B1 (Tab. I) were per-
formed to comparatively analyse the clinical, vi-
rological and serological course of an infection
with two different avirulent serotype I FECV
strains and to investigate whether persistent
infection could be established. FECV UCD and
FECV RM are independent virus isolates,
maintained in cats only, and ﬁrst described by
Pedersen et al. [23] and Hickman et al. [14],
respectively.Theviruseswereappliedbythenat-
ural route, i.e. by oronasal inoculation. Two cats
were inoculated with FECV UCD and four cats
with FECV RM.
All six cats were successfully infected and
both infections persisted as indicated by faecal
virus shedding which lasted for at least 35 days
(strain UCD) and 71 days (strain RM), i.e. until
the time the experiment was terminated and the
animals euthanized. Faecal virus shedding, as
monitored by TaqMan
  RT-PCR, became read-
ily detectable from day 1 to 3 post inoculation
and increased rapidly up to 10
7 genomes/lL
faeces in all animals. All cats seroconverted as
determined both by RIPA and by ELISA (data
not shown; detailed data are provided below
for the dose-titration experiments).
The two cats inoculated with FECV UCD
had diminished appetite at several days in the
period between day 5 and day 16 after inocula-
tion and experienced weight loss during the ﬁrst
eight days after inoculation. The cats inoculated
with FECV RM did not show any clinical signs
of disease during the entire experimental period.
They exhibited normal behaviour and the con-
sistency of their faeces was also normal.
3.2. Effect of inoculation dose on infection
outcome
To obtain a more detailed and comparative
insight into FECV UCD and FECV RM infec-
tion and into the effect of virus dose on the out-
come and persistence of infection, experiments
A2 and B2 wereperformed.In both theseexper-
iments eight cats placed in groups of two were
inoculated with different doses of the two
viruses, ranging from 5 · 10
5 to 2 · 10
10 gen-
ome equivalents. All cats, even those inoculated
with the lowest viral dose, became infected, as
indicated by their faecal virus shedding and
seroconversion. Virus shedding became detect-
able already one day after inoculation with the
two highest doses of FECV UCD and two days
after inoculation of the cats with the two lowest
doses of this virus. Shedding of FECV RM was
ﬁrst detected at day 2 in the animals that
received the two highest doses and on day 3 in
the cats inoculated with the two lowest doses
(Fig. 1). In all animals, the amount of virus in
the faeces subsequently increased within two
days to peak levels of 10
6–10
8 genomes/lL fae-
ces, after which shedding remained high for an
extended period until day 16 and day 23 post
inoculation in FECV UCD and FECV RM
infected cats, respectively. Thereafter the virus
titres in the faeces declined. Shedding seemed
to decline more steeply in cats that had received
the lowest viral doses. This was particularly the
case for the FECV RM infected animals where
virus was no longer detected from day 42 after
inoculation with the 10
 3 or 10
 4 diluted doses.
3.3. Serological responses to infection
AllcatsdevelopedFCoV-speciﬁcserumanti-
bodies as determined by ELISA and RIPA
(Figs. 2 and 3). The kinetics of appearance of
the antibodies was comparable for both viruses.
As illustrated for the FECV UCD infections in
Figure2,theantibodiesstartedtobecomedetect-
able at 10 days post inoculation. There was a
clear tendency for the animals infected with the
higher doses to develop somewhat higher,
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iesrecognizedtheFCoVstructuralproteinsM,N
and S as determined by RIPA (Fig. 3). Antibod-
ies to the N protein were predominant and the
ﬁrst to become detectable by this assay.
3.4. Clinical observations
All FECV UCD infected cats showed dimin-
ished appetite between days 3 through 15 post
inoculation, resulting in loss of body weight
gain (Fig. 4). However, the animals produced
normal stools and did not show any other signs
of disease, with the exception of two cats. One
cat, inoculated with undiluted faecal extract,
developed a chronic fever at day 5, which sub-
sided after day 40. The other cat, inoculated
with 10
 3 diluted faecal extract, developed a
recurring fever, with temperatures   40  Co n
days 2, 26, 35, 40 and 62 post inoculation.
The body temperature of the remaining cats
stayed between 37.6 and 40.0  C throughout
the experiment. Interestingly, two cats, inocu-
l a t e dw i t ha1 0
 3 and a 10
 2 dilution, respec-
tively, which were apparently able to contain
the persistent infection and to reduce viral titres
in the faeces, showed a stronger increase in
body weight than the other animals (Fig. 4).
Figure 1. Faecal shedding of virus by cats included in infection experiments A2 and B2 after inoculation
with FECV UCD (A) or FECV RM (B), as monitored by TaqMan
  RT-PCR. Means per group (n = 2).
Note that RNA quantities below 3 · 10
3 cannot be considered accurate (real quantities are probably lower)
due to the non-linear relationship between input RNA and Ct value in the assay in the lower concentration
range.
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without weight loss or growth retardation, and
showed no clinical signs of disease during the
entire experimental period. The disease signs
observed with the UCD strain are thus unlikely
to be caused by experimental conditions such as
manipulation-induced stress.
The FECV infections had no effects on the
number of peripheral blood lymphocytes. Their
numbers remained stable irrespective of the
viral strain or dose when counted at various
times post inoculation (data not shown).
3.5. Viral RNA in blood
The presence of virus in blood was tested
by performing a real-time RT-PCR on whole
EDTA blood of FECV UCD infected cats.
The results of these assays were variable. Often
no viral RNA was detected and, if positive, no
clear pattern was observed, as illustrated by
Figure 5. No sign of viral replication in the
blood of these two animals could be detected
as judged by an RT-PCR assay targeting subge-
nomic mRNA for the viral M protein.
3.6. Post mortem localization of virus in
the digestive tract during viral persistence
In order to determine in which part(s) of the
gut virus was present during viral persistence,
Figure 2. Serum antibody titres, detected with ELISA, in cats included in infection experiment A2 after
inoculation with FECV UCD. Means per group (n = 2).
Figure 3. RIPA with serum from one representa-
tive cat inoculated with a 10
 2 diluted dose of
FECV RM (experiment B2). A lysate of
35S-methionine labelled FCWF cells infected with
FIPV strain 79-1146 was used for the immunopre-
cipitations. MW: molecular weight markers, of
which the molecular sizes (kDa) are indicated at the
left; lane 1; ascitis 9912; lane 2: anti-RM plasma;
lane 3–7: serum collected from the cat one day
before inoculation and at days 13, 23, 43 and 50
after inoculation, respectively. Note the relatively
poor recognition of the serotype II viral spike (S)
protein by the serotype I sera.
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of two FECV UCD infected cats. These ani-
mals, from a similar infection experiment not
described here, were still shedding virus at days
64 and 68 days post inoculation, the time they
were euthanized. Their intestines were sec-
tioned over their entire length in 5-cm (from
stomach up to the appendix) and 1-cm seg-
ments (remainder). Viral RNA in each segment
was determined by real-time RT-PCR. As
shown in Figure 6, no virus was detectable in
the ﬁrst approximately 150 cm long part com-
prising duodenum, jejunum and ileum. In both
animals virus was found only in the approxi-
mately 15–20 cm ﬁnal part of the gut, down-
stream of the appendix, i.e. in colon and
rectum. While viral RNA was found in the fae-
ces part of essentially all segments of these
Figure 4. Body weight of FECV UCD-inoculated cats included in infection experiment A2. Cats 119 and
089 were inoculated with undiluted faecal extract, cats 129 and 091 with a 10
 1 dilution, cats 093 and 131
with a 10
 2 dilution, and cats 125 and 136 with a 10
 3 dilution of the faecal extract. The upper ﬁgure shows
an expanded view of the initial phase of the infection.
Figure 5. Viral genomic RNA in blood. Two 17-weeks-old cats were inoculated with a 10
 2 dilution
of FECV UCD stock. Genomic RNA was determined in blood cells by real-time RT-PCR.
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in several of the corresponding tissue speci-
mens, suggesting that at this late stage of persis-
tence the number or areas of virus-producing
cells have become scarce. Consistent with this
interpretation, attempts to visualize infected
cells in ﬁxed sections of the epithelial lining
of the intestines by immunoperoxidase staining
were unsuccessful.
4. DISCUSSION
While there is quite a number of reports
describing natural infections caused by the pre-
valent serotype I FCoV [1, 2, 6–8, 13, 17, 21],
studies investigating the course of FECV infec-
tion after controlled experimental infection are
remarkably few [6, 21, 23, 24]. Yet, such stud-
ies are important as detailed knowledge about
the biology of this infection should eventually
allow us to better understand the conditions
and requirements that give rise to the fatal
pathotypic shift to FIP. These insights in turn
might provide leads to prevent this transition
or treat the disease. Here we describe the results
of four infection experiments in which persis-
tent infection was reproducibly established
and in which we analysed a number of clinical,
virological and serological parameters.
Inoculation through the natural, oronasal
route invariably initiated an immediate infection
as judged by the rapid onset of shedding of
virus with the faeces. At the highest doses shed-
ding started already at day 1 (strain UCD) and
2 (strain RM), at lower doses within three days
after inoculation. Titres rose rapidly, peaking
about two days later at 10
6–10
8 genome equiv-
alents/lL irrespective of the dose and staying
high thereafter for the next 2 to 3 weeks. Shed-
ding continued during the subsequent two
months at a gradually but slowly decreasing
level except for the four animals inoculated
with the lowest FECV RM doses, which all
ceased shedding from about 6 weeks onwards.
These results are in part consistent with a study
by Pedersen et al. [24] in which experimentally
infected cats were systematically monitored
over longer (8–48 months) periods. Based on
the shedding patterns of the 29 cats that had
been inoculated orally with (an unknown dose
of) FECV strain RM, the authors of this study
distinguished three excretion types: persistent,
intermittent and self-limiting. Though our mon-
itoring period was too short to allow such clas-
siﬁcation, the shedding patterns we observed
Figure 6. Virus in the intestinal tract during persistent FECV infection. Two cats inoculated with a 10
 1
dilution of FECV UCD stock were euthanized 64 and 68 days later while still shedding virus. Intestines
were sectioned into 5-cm (from stomach to appendix) and 1-cm segments (downstream of appendix) and the
viral RNA in faecal content and intestinal tissue was determined for each segment by real-time RT-PCR.
Section numbers refer to the following parts of the gut. For cat 146: 1–10, duodenum; 10–156, jejunum and
ileum; 157–166, colon; 167–177, rectum. For cat 150: 1–10, duodenum; 10–160, jejunum and ileum; 160–
177, colon; 178–184, rectum.
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dose can affect the type of excretion, lower
doses giving rise to earlier clearance of the
infection than higher doses. This is remarkable
in view of the comparable excretion levels at
the peak of shedding. For the UCD strain this
distinction could not be made.
Within therange ofinoculationdosesthat we
used in our dose titration experiments, the
threshold below which infection becomes inef-
fective was not reached. The observations in
Figure 1 suggest that rather low doses are prob-
ably sufﬁcient to establish FECVinfection, con-
sistent with the efﬁcient spread of the virus in
the ﬁeld. For FECV UCD our lowest dose was
5 · 10
5 genome equivalents. The average
amount ofthis virus shedduring the ﬁrst 45 days
of the infection was around 5 · 10
5 genomes/
lL. From this it is clear that only traces of the
faeces from such infected cats will already suf-
ﬁce to initiate an infection in a new host.
All FECV UCD and FECV RM infectedcats
seroconverted starting approximately 10 days
after inoculation. During the next weeks the
serumIgGtitresincreasedbuttheyneverreached
high levels. These systemic antibodies, which
were directed against all major viral structural
proteins, were obviously unable to efﬁciently
clear the local FECV infection as shedding of
viruswiththefaecescontinuedintheirpresence.
Our observations are consistent with the few
reports regarding immune responses to experi-
mental FECV infection, and in which low and
often variable antibody titres were found in
serum or plasma [21, 24, 26]. Little is known
about mucosal immune responses to FECV
infection in the gut. Though probably the most
important for the control and clearance of the
infection, local immunity is evidently inade-
quate. It is quite conceivable that this failure is
due to interference of viral factors with the
immune system.
FECV replicates in the gastrointestinal tract
[13, 23]. Using RT-PCR, viral RNA has how-
ever also been observed by us [12, 13, 28]
and others [7, 17, 18, 21] in blood, some organs
and haemolymphatic tissues of naturally
infected cats; in experimentally infected ani-
mals viral RNA appeared hard to detect in
PBMC (this study) or blood monocytes [21].
The signiﬁcance of the apparent viraemia is still
enigmatic. While cells of the monocyte lineage
are the prime targets of FIPV, these cells are
poorly susceptibility to FECV and support its
replication and spread very inefﬁciently, at least
in vitro [27, 29]. In one study using blood from
22 cats, the monocytes from three cats were not
susceptible to FECV while the cells from the
other animals could be infected but did not sus-
tain the infection [5]. Studies using an RT-PCR
targeting viral mRNA to detect FCoV replica-
tion suggest this situation to be the case as well
in vivo [13, 28]; actually, viral mRNA or
infected cells could not be observed in organs
other than the intestinal tract. Apparently,
FECV is picked up by mononuclear cells in
the gut and carried to organs and tissues with
the blood. Consistently, while studying haem-
olymphatic tissues, a major site for the accumu-
lation of monocytes/macrophages, Kipar et al.
found signiﬁcantly higher levels of viral RNA
in cats with FIP than in healthy FCoV positive
cats [17]. Moreover, FCoV antigen was detect-
able by immunohistology in these tissues only
in FIP cats [17, 18], conﬁrming the low FECV
replication activity in the mononuclear cells.
FECV is tropic for cells of the mature apical
epithelium of the intestinal villi, targeting cells
from the caudal part of the duodenum to the
cecumduringacuteinfection[23].Inchronically
infectedanimalsthelowerpartofthegastrointes-
tinal tract was identiﬁed as a major site of viral
replication, as indicated by RT-PCR detection
of viral mRNA and by immunohistochemical
detection of infected cells [13]. Consistent with
theseﬁndings,duringexperimentallyestablished
persistent infection we only observed FECV in
the large intestine, downstream of the appendix,
i.e. in colon and rectum. During the submission
processofthismanuscriptapublicationbyKipar
et al. [19] appeared in which the colon was also
identiﬁed as the major site of FCoV persistence.
FECV are known as low- or non-virulent
pathogens. Whether and to what extent viru-
lence variation occurs is not really clear; no vir-
ulence variants have so far been described. Here
we studied two independent FECV strains iso-
lated from cats many years apart and main-
tained by cat-to-cat passage only. Interestingly,
the two viruses behaved reproducibly different,
Vet. Res. (2010) 41:71 L. Vogel et al.
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genic than the RM strain, also when applied
to older kittens (data not shown). In both infec-
tion experiments with FECV RM the cats grew
normally, remained without fever, produced
normal stools and did not show obvious signs
of disease. In contrast, the FECV UCD infected
cats had diminished appetite and exhibited
weight loss early after inoculation. Two of the
cats developed chronic or recurrent fever, as
observed also with another FECV isolate [21].
The results indicate that variation in FECV
pathogenicity does indeed occur. Still, these
viruses seem to have evolved a rather harmoni-
ous relationship with their host, a peaceful
coexistence that is threatened only by the ability
of these viruses to suddenly turn into killers,
FIPV. It remains enigmatic how, why and to
what evolutionary advantage this mutational
feature is apparently being conserved so well.
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